We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Fluidigm

Fluidigm Corporation focuses on the most pressing needs in translational and clinical research, including cancer, imm... read more Featured Products: More products

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Genetic and Lifestyle Factors Effect Biomarker Variation

By LabMedica International staff writers
Posted on 01 Sep 2014
Print article
Fluidigm\'s Biomark HD real-time polymerase chain reaction platform
The Biomark HD real-time polymerase chain reaction platform (Photo courtesy of Fluidigm)
Ideal biomarkers used for disease diagnosis should display deviating levels in affected individuals only and be robust to factors unrelated to the disease.

A detailed understanding of potential confounding factors and their effect size is therefore a necessary prerequisite in the evaluation of the rapidly growing number of candidate biomarkers.

Scientists at the Uppsala University (Sweden) analyzed 92 potential protein biomarkers for cancer and inflammation in plasma from 1,005 individuals in a longitudinal cross-sectional population-based study. The biomarkers analyzed constituted an exploration panel directed against multiple cancers and also contain proteins implicated in autoimmune diseases such as rheumatoid arthritis (RA) and Graves’ disease.

For the proximity extension assay protein levels in plasma were analyzed using the Proseek Multiplex Oncology I 96 × 96 kit (Olink Bioscience; Uppsala, Sweden) and quantified by real-time polymerase chain reaction (PCR) using the BioMark HD) real-time PCR platform (Fluidigm; South San Francisco, CA, USA). The team selected 100 individuals, for Whole-Exome Sequencing using the SureSelect system for exome capture (Agilent; Santa Clara, CA, USA) and the SOLiD 5500xl instrumentation for sequencing (Applied Biosystems; Foster City, CA, USA).

The scientists found that for 75% of the biomarkers, the levels are significantly heritable and genome-wide association studies identified 16 novel loci and replicate two previously known loci with strong effects on one or several of the biomarkers. Integrative analysis attributes as much as 56.3% of the observed variance to non-disease factors. They proposed that information on the biomarker-specific profile of major genetic, clinical and lifestyle factors should be used to establish personalized clinical cutoffs, and that this would increase the sensitivity of using biomarkers for prediction of clinical end points.

Stefan Enroth, PhD, the lead author of the study, said, “These results are important, as they show which variables are significant for variations in the measurable values. If these factors are known, we have a greater possibility of seeing variations and we get clearer breakpoints between elevated values and normal values. By extension this may lead to the possibility of using more biomarkers clinically.” The study was published on August 22, 2014, in the journal Nature Communications.

Related Links:

Uppsala University
Olink Bioscience 
Fluidigm 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.